Healthcare

Truth in biosimilar labeling

Recently the FDA issued draft guidance on labeling for biosimilar products.

In two words, no surprises – which for some is better news than for others.

The top of Page 8 will get a lot of attention:

FDA...

Read More...

Healthy aging begins at home

With the aging of the 78 million Baby Boomers, America’s senior population is poised to grow dramatically over the next fifteen years. By 2030, seniors 65 and older will represent more than 20 percent of the U.S. population, up from 14 percent...

Read More...

Want better health coverage? Change your Zip Code

 

One of the nation's largest Medicare contractors just decided that it won't cover a proven new heart monitor that tracks signs of heart failure. That's terrible news for millions of Americans suffering from cardiac disease.

It'...

Read More...

FDA drug labelling rule change unnecessary

On their way out of town, Obama administration regulators are seeking to deliver one last favor for their friends the trial lawyers. 

Regulators at the Food and Drug Administration are trying to change the rules regarding labeling on...

Read More...

The Sunshine Act: Transparency, but not enough action

This year the pharmaceutical industry has been relentlessly targeted for criticism by virtually all major candidates, regardless of political party. You would think that the industry is a mortal enemy of our nation.

It is unfortunate that...

Read More...

When drug prices threaten patient care

The debate over high drug prices has raged for decades, thanks to the inherent tension between delivering innovative and cost-effective patient care. But recently something has changed, and it’s one that may have major ramifications for how we...

Read More...

Pages